- BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin
-
Bansal N, Marchion D, Bicaku E, Xiong Y, Chen N, Stickles X, Sawah EA, Wenham RM, Apte SM, Gonzalez-Bosquet J, Judson PL, Hakam A, Lancaster
- KMID: 2177512
- J Gynecol Oncol.
- 2012 Jan;23(1):35-42.
- doi: 10.3802/jgo.2012.23.1.35
OBJECTIVE: The BCL2 family proteins are critical mediators of cellular apoptosis and, as such, have been implicated as determinants of cancer cell chemo-sensitivity. Recently, it has been demonstrated that the... -
- CITED
-
- Close
- SHARE
-
- Close
